| Year |
Citation |
Score |
| 2021 |
Leystra AA, Gilsdorf BJ, Wisinger AM, Warda ER, Wiegand S, Zahm CD, Matkowskyj KA, Deming DA, Khan N, Rosemarie Q, Sievers CK, Schwartz AR, Albrecht DM, Clipson L, Mukhtar H, et al. Multi-ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy. Cancer Reports (Hoboken, N.J.). e1459. PMID 34245130 DOI: 10.1002/cnr2.1459 |
0.754 |
|
| 2020 |
Potluri HK, Hernandez R, Zahm CD, Grudzinski J, Massey C, Weichert J, McNeel DG. Abstract 2262: Low-dose targeted radionuclide therapy has favorable local and systemic effects on immune populations in a murine prostate cancer model Immunology. DOI: 10.1158/1538-7445.Am2020-2262 |
0.301 |
|
| 2019 |
Zahm CD, Johnson LE, McNeel DG. Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 31606777 DOI: 10.1007/S00262-019-02394-W |
0.526 |
|
| 2019 |
Hernandez R, Walker KL, Grudzinski JJ, Aluicio-Sarduy E, Patel R, Zahm CD, Pinchuk AN, Massey CF, Bitton AN, Brown RJ, Sondel PM, Morris ZS, Engle JW, Capitini CM, Weichert JP. Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma. Communications Biology. 2: 79. PMID 30820474 DOI: 10.1038/s42003-019-0327-4 |
0.452 |
|
| 2019 |
Scarpelli M, Zahm C, Perlman S, McNeel DG, Jeraj R, Liu G. FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab. Journal For Immunotherapy of Cancer. 7: 23. PMID 30700328 DOI: 10.1186/S40425-019-0516-1 |
0.386 |
|
| 2018 |
McNeel DG, Eickhoff JC, Wargowski E, Zahm C, Staab MJ, Straus J, Liu G. Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer. Oncotarget. 9: 25586-25596. PMID 29876010 DOI: 10.18632/Oncotarget.25387 |
0.496 |
|
| 2017 |
Zahm CD, Colluru VT, McNeel DG. DNA Vaccines for Prostate Cancer. Pharmacology & Therapeutics. PMID 28185916 DOI: 10.1016/J.Pharmthera.2017.02.016 |
0.355 |
|
| 2016 |
Colluru VT, Zahm CD, McNeel DG. Mini-intronic plasmid vaccination elicits tolerant LAG3(+) CD8(+) T cells and inferior antitumor responses. Oncoimmunology. 5: e1223002. PMID 27853647 DOI: 10.1080/2162402X.2016.1223002 |
0.428 |
|
| 2016 |
Zahm CD, Szulczewski JM, Leystra AA, Paul Olson TJ, Clipson L, Albrecht DM, Middlebrooks M, Thliveris AT, Matkowskyj KA, Washington MK, Newton MA, Eliceiri KW, Halberg RB. Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture. Plos One. 11: e0150170. PMID 26919712 DOI: 10.1371/Journal.Pone.0150170 |
0.81 |
|
| 2016 |
Leystra AA, Luers B, Son J, Sievers CK, Wisinger AM, Schwartz AR, Zahm CD, Matkowskyj KA, Albrecht DM, Clipson L, Deming DA, Newton MA, Halberg RB. Abstract 2381: A multiancestral model of colorectal cancer:in vivoevidence that early heterogeneity contributes to cancer progression Cancer Research. 76: 2381-2381. DOI: 10.1158/1538-7445.Am2016-2381 |
0.795 |
|
| 2016 |
Zahm CD, McNeel DG. Abstract 2362: Optimizing prostate cancer immunotherapy by reducing vaccine induced PD-1 expression Cancer Research. 76: 2362-2362. DOI: 10.1158/1538-7445.Am2016-2362 |
0.394 |
|
| 2015 |
Leystra AA, Wisinger AM, Zahm CD, Matkowskyj KA, Sievers CK, Schwartz A, Albrecht DM, Clipson L, Deming DA, Newton MA, Halberg RB. Abstract 4143: Discrete clones cooperate to promote tumor progression through a non-cell-autonomous mechanism in intestinal cancers Cancer Research. 75: 4143-4143. DOI: 10.1158/1538-7445.Am2015-4143 |
0.805 |
|
| 2015 |
Zahm CD, McNeel D. Abstract 2501: Vaccination using epitopes with higher MHC class I affinity elicits CD8+ T cells with increased PD-1 expression Cancer Research. 75: 2501-2501. DOI: 10.1158/1538-7445.Am2015-2501 |
0.406 |
|
| 2014 |
Paul Olson TJ, Hadac JN, Sievers CK, Leystra AA, Deming DA, Zahm CD, Albrecht DM, Nomura A, Nettekoven LA, Plesh LK, Clipson L, Sullivan R, Newton MA, Schelman WR, Halberg RB. Dynamic tumor growth patterns in a novel murine model of colorectal cancer. Cancer Prevention Research (Philadelphia, Pa.). 7: 105-13. PMID 24196829 DOI: 10.1158/1940-6207.Capr-13-0163 |
0.702 |
|
| 2014 |
Leystra AA, Deming DA, Wisinger AM, Zahm CD, Sievers CK, Matkowskyj KA, Albrecht DM, Newton MA, Halberg RB. Abstract 1935: Transformation of epithelial cells through recruitment leads to polyclonal intestinal cancers Cancer Research. 74: 1935-1935. DOI: 10.1158/1538-7445.Am2014-1935 |
0.804 |
|
| 2013 |
Thliveris AT, Schwefel B, Clipson L, Plesh L, Zahm CD, Leystra AA, Washington MK, Sullivan R, Deming DA, Newton MA, Halberg RB. Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors. Proceedings of the National Academy of Sciences of the United States of America. 110: 11523-8. PMID 23798428 DOI: 10.1073/Pnas.1303064110 |
0.781 |
|
| 2013 |
Zahm CD, Szulczewski J, Olson TJP, Nettekoven L, Leystra A, Albrecht DM, Clipson L, Eliceiri KW, Newton MA, Halberg RB. Abstract 2717: The clonal architecture of tumors in the mammalian intestines. Cancer Research. 73: 2717-2717. DOI: 10.1158/1538-7445.Am2013-2717 |
0.801 |
|
| 2012 |
Leystra AA, Deming DA, Zahm CD, Farhoud M, Olson TJ, Hadac JN, Nettekoven LA, Albrecht DM, Clipson L, Sullivan R, Washington MK, Torrealba JR, Weichert JP, Halberg RB. Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Research. 72: 2931-6. PMID 22525701 DOI: 10.1158/0008-5472.Can-11-4097 |
0.69 |
|
| 2011 |
Thliveris AT, Clipson L, White A, Waggoner J, Plesh L, Skinner BL, Zahm CD, Sullivan R, Dove WF, Newton MA, Halberg RB. Clonal structure of carcinogen-induced intestinal tumors in mice. Cancer Prevention Research (Philadelphia, Pa.). 4: 916-23. PMID 21636550 DOI: 10.1158/1940-6207.Capr-11-0022 |
0.762 |
|
| Show low-probability matches. |